Skip to main content
ZVRA logo

ZVRA · Zevra Therapeutics, Inc. · Analyst Estimates

Track ZVRA — free
$9.19 -0.09 (-0.97%) Play latest call Q3 2026 earnings call transcript
Market Cap
$552.20M
Shares
59.50M
Volume · Nov 19 72.54K Avg daily vol (3M) 954.6K

Analyst Estimates

Compare analyst forecasts for Zevra Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-18 06:16 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.12
1.27
1.42
2
1.27
1.14
1.14
1.14
0
0
0
0
Revenue
USD
Publication date not stated
150.00M
153.12M
156.90M
9
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.75
0.89
1.08
4
0.95
1.05
1.05
1.05
0
0
0
0
Revenue
USD
Publication date not stated
157.10M
176.54M
196.20M
9
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.14
0.19
0.23
4
0.19
0.20
0.20
0.20
0
0
0
0
Revenue
USD
Publication date not stated
37.30M
40.08M
43.26M
9
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.15
0.20
0.27
3
0.20
0.30
0.30
0.30
0
0
0
0
Revenue
USD
Publication date not stated
33.90M
38.84M
41.80M
5
— — — — — — — —
Key facts CIK 1434647 CUSIP 488445206 13F (30d) 188 filings 164 filers Visit website Investor relations